Related Experiment Video
Updated: Jun 23, 2025

07:28
TChIP-Seq: Cell-Type-Specific Epigenome Profiling
Published on: January 23, 2019
7.7K
Haplotype Inference Using Long-Read Nanopore Sequencing: Application to GSTA1 Promoter
Vid Mlakar1, Isabelle Dupanloup2,3, Yvonne Gloor2
1CANSEARCH Research Laboratory, Geneva University Medical School, Rue Michel Servet 1, 1211, Geneva, Switzerland. vid.mlakar@unige.ch.
Molecular Biotechnology
|June 17, 2024
Summary
Oxford Nanopore sequencing accurately recovers true GSTA1 promoter haplotypes, overcoming challenges of traditional inference methods. This long-read technology offers a robust approach for precise haplotype phasing in clinical genetics.
Area of Science:
- Genetics
- Molecular Biology
- Bioinformatics
Background:
- Accurate haplotype recovery is clinically significant but challenging in laboratories, often relying on inference.
- The GSTA1 promoter region presents specific phasing difficulties due to potentially ambiguous haplotypes.
Purpose of the Study:
- To evaluate the efficacy of Oxford Nanopore sequencing technology for phasing GSTA1 promoter haplotypes.
- To compare Oxford Nanopore sequencing results with Sanger sequencing and existing inferred haplotypes.
Main Methods:
- Utilized Oxford Nanopore sequencing on eight LCL cell lines with ambiguous haplotypes.
- Sequenced a 1336 bp PCR product of the GSTA1 promoter region, achieving an average read length of 813 bp.
- Compared phasing accuracy with Sanger sequencing and data from the 1000 Genomes Project.
Main Results:
- Oxford Nanopore sequencing successfully recovered true haplotypes for the GSTA1 promoter region.
- High accuracy (>90%) was achieved for SNPs closer than 200 bp, with over 58% accuracy for SNPs 1089 bp apart.
- Sequencing coverage was optimal in the middle of the PCR product, decreasing towards the ends.
Conclusions:
- Long-read Oxford Nanopore sequencing provides an accurate and robust method for determining true haplotypes without inference.
- Phasing success is dependent on SNP distances and frequencies, highlighting the technology's potential in clinical applications.
- The number of PCR cycles impacts hybrid haplotype generation, but not extension or annealing times.

